Swiss startup creates modular device for on-demand cell therapy manufacturing
Briefly

Limula's modular device merges bioreactor and centrifuge functions, eliminating transfer steps, reducing cell stress, losses, and batch contamination.
The device allows higher control in cell manipulation and is scalable from pre-clinical to commercial-scale manufacturing, making cell therapy more accessible.
Read at TNW | Deep-Tech
[
add
]
[
|
|
]